There was a trend towards an increased risk of major bleeding in the active treatment group, however this did not reach statistical significance (OR 1.64; 95% CI 0.69–3.90, NS) (See Fig 3 ).
← all excerpts
Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
1
—
—